GlassScriptPhysician profile
Sondra Smith
NPI 1164759957
$3,762.15
in general payments reported to CMS, 2019-2025
16 companies · $917 in 2025
The $917 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $582 · 2022: $462 · 2023: $611 · 2024: $1,190 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,497.41 | 2021-2025 | |
| Amgen INC. | $672.91 | 2021-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $436.48 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $380.17 | 2021-2025 | Mounjaro, Emgality, Zepbound |
| Novo Nordisk INC | $274.94 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $114.37 | 2024-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $102.68 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $71.11 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.44 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.20 | 2025 | Caplyta |
| Pfizer INC. | $36.48 | 2025 | |
| Axsome Therapeutics, INC. | $22.22 | 2025 | Auvelity |
| Sanofi Pasteur INC. | $20.81 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $16.79 | 2025 | Abilify Maintena, Abilify Asimtufii |
| Glaxosmithkline, LLC. | $16.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sondra Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.